140 results on '"Cuzzola, Maria"'
Search Results
2. Tolerability and Efficacy of Busulfan and Fludarabine As Allogeneic Pretransplant Conditioning Therapy in Acute Myeloid Leukemia: Comparison With Busulfan and Cyclophosphamide Regimen
3. Knowledge Discovery and Risk Prediction for Chronic Diseases: An Integrated Approach
4. Incremental – Adaptive – Knowledge Based – Learning for Informative Rules Extraction in Classification Analysis of aGvHD
5. Multidimensional 3-Month Follow-Up of Severe COVID-19: Airways beyond the Parenchyma in Symptomatic Patients
6. Machine Learning and Personalized Modeling Based Gene Selection for Acute GvHD Gene Expression Data Analysis
7. Ontology Based Personalized Modeling for Type 2 Diabetes Risk Analysis: An Integrated Approach
8. Discovering Diagnostic Gene Targets and Early Diagnosis of Acute GVHD Using Methods of Computational Intelligence over Gene Expression Data
9. A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes
10. Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
11. Comparative study of existing personalized approaches for identifying important gene markers and for risk estimation in Type2 Diabetes in Italian population
12. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1
13. Thalidomide and discoid lupus erythematosus: case series and review of literature
14. NGS Evaluation of the Eqol-MDS Trial: Preliminary Analysis of Eltrombopag for Thrombocytopenia of Low-Risk MDS
15. Pneumothorax and/or Pneumomediastinum Worsens the Prognosis of COVID-19 Patients with Severe Acute Respiratory Failure: A Multicenter Retrospective Case-Control Study in the North-East of Italy
16. Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality
17. Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study
18. Neonatal Hypersusceptibility to Endotoxin Correlates with Increased Tumor Necrosis Factor Production in Mice
19. Advances in medical decision support systems for diagnosis of acute graft-versus-host disease: molecular and computational intelligence joint approaches
20. Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients
21. Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia
22. Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?
23. Incremental – Adaptive – Knowledge Based – Learning for Informative Rules Extraction in Classification Analysis of aGvHD
24. Knowledge Discovery and Risk Prediction for Chronic Diseases: An Integrated Approach
25. Machine Learning and Personalized Modeling Based Gene Selection for Acute GvHD Gene Expression Data Analysis
26. Discovering Diagnostic Gene Targets and Early Diagnosis of Acute GVHD Using Methods of Computational Intelligence over Gene Expression Data
27. Ontology Based Personalized Modeling for Type 2 Diabetes Risk Analysis: An Integrated Approach
28. Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion
29. First utilization of BioFire FilmArray® Respiratory Panel 2 Plus in post-mortem diagnosis of Influenza A H1N1
30. Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombo- cythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders
31. A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model
32. Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome
33. Novel Gene Mutations Associated with Disease-Free Survival in Elderly Patients with Acute Myeloid Leukemia Receiving First-Line Induction-Consolidation with or without Azacitidine Post-Remission Treatment
34. Role of IL-10 in a Neonatal Mouse Listeriosis Model
35. Fast and Non-Invasive Identification of Tumorigenic-Proliferative Biomarker in Myeloproliferative and Lymphoproliferative Disorders
36. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy
37. Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience
38. Erythroid but not cytogenetic response in a case with 5q− syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?
39. Comparative study of existing personalized approaches for identifying important gene markers and for risk estimation in Type2 Diabetes in Italian population
40. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.
41. Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study
42. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood
43. Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease
44. Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.
45. Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.
46. Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?
47. Gene Expression Profile (GEP) Analysis as a Tool to Control the Efficacy Dasatinib Treatment in Relapsed Imatinib-Resistant CML Patients Previously Undergone to Allogeneic Stem Cell Transplantation. Preliminary Data of a Single Institution
48. β2 Integrins Are Involved in Cytokine Responses to Whole Gram-Positive Bacteria
49. Human Monocyte Receptors Involved in Tumor Necrosis Factor Responses to Group B Streptococcal Products
50. Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.